GLP1R and Parkinson disease: Then, we evaluated the neuroprotective effects of EcN‐GLP‐1 treatment on the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP)‐induced PD mice.